1-benzylpiperidine has been researched along with isoxazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bautista-Aguilera, OM; Chioua, M; Colmena, I; Criado, M; Gandía, L; Marco-Contelles, J; Mulet, J; Sala, F; Sala, S; Samadi, A | 1 |
| Akbarzadeh, T; Edraki, N; Felegari, P; Firuzi, O; Hariri, R; Iraji, A; Mahdavi, M; Mirfazli, SS; Rastegari, A; Saeedi, M | 1 |
2 other study(ies) available for 1-benzylpiperidine and isoxazoles
| Article | Year |
|---|---|
N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Calcium; Cell Line, Tumor; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Isoxazoles; Membrane Potentials; Microinjections; Neuroblastoma; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Patch-Clamp Techniques; Phenylurea Compounds; Piperidines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Serotonin; Xenopus laevis | 2016 |
Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoxazoles; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; PC12 Cells; Piperidines; Rats; Structure-Activity Relationship | 2021 |